经口等离子射频手术治疗下咽癌的可行性与疗效
回顾性分析2010—2016年接受等离子射频辅助经口手术治疗的下咽癌患者22例,其中20例顺利完成经口手术,2例因不能确保安全切缘中转开放手术。完成随访的18例中3例局部复发(16.7%),5年局部控制率57.8%、总体生存率67.5%,随访中均未发现发音、吞咽及呼吸功能障碍。
要点
- 22例中20例顺利完成经口手术,2例因不能确保安全切缘中转开放手术。
- 完成随访18例中局部复发3例(16.7%),5年局部控制率57.8%、总体生存率67.5%。
- 随访中所有患者均未发现发音、吞咽及呼吸功能障碍。
核心结论
- 等离子射频辅助经口手术治疗下咽癌可行,切割效率高及控制术中出血更佳有助于降低手术难度,随访数据证实疗效确切且功能保留率高。
研究设计与样本
- 回顾性分析2010—2016年接受等离子射频辅助经口手术(TOS)治疗的下咽癌患者22例,其中梨状窝癌15例、环后癌4例、下咽后壁癌3例。
主要发现
- 22例中2例因肿瘤范围超过术前评估、不能确保安全切缘而中转开放手术,其余20例顺利完成TOS。
- 术后除1例因疼痛恢复经口进食较慢外,其余患者均在1周内恢复经口进食。
- 完成随访的18例中3例(16.7%)局部复发,其中1例(5.6%)因局部复发、多原发食管癌及远处转移于术后4年死亡。
- Kaplan-Meier法计算5年局部控制率为57.8%,总体生存率为67.5%。
- 所有患者在随访中均未发现发音、吞咽及呼吸功能等方面的障碍。
关键数值与推荐
- 根据AJCC 2002年指南,分期为T1N0M0者3例、T2N0M0者9例、T1N1M0者1例、T1N2M0者1例、T2N1M0者4例、T2N2M0者4例。
- 所有术前评估存在淋巴结转移的患者均接受同期颈淋巴清扫术,2例接受同期预防性气管切开术。
- 17例患者接受术后放射治疗,剂量范围为50~66 Gy。
- 术后随访时间范围为6~72个月,中位值35个月,2例失访。
临床怎么用
- 等离子射频辅助经口手术可作为下咽癌的治疗选择,其切割效率高及控制术中出血更佳的特点有助于降低手术难度。
- 术前评估存在淋巴结转移者行同期颈淋巴清扫术,部分患者可行同期预防性气管切开术,部分患者术后接受放射治疗。
- 随访中患者发音、吞咽及呼吸功能均未见障碍,功能保留率高。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To explore the feasibility and effectiveness of transoral surgery (TOS) for the treatment of hypopharyngeal carcinoma by means of the radiofrequency coblation(RFC). Methods: Twenty-two patients with hypopharyngeal carcinoma who were treated with TOS using RFC during the years of 2010-2016 were enrolled. Among these patients, 15 suffered from pyriform sinus carcinoma, 4 suffered from postcricoid carcinoma, and 3 suffered from posterior hypopharyngeal wall carcinoma. According to the AJCC 2002 guideline, the tumor stages were T1N0M0 for 3 patients, T2N0M0 for 9 patients, T1N1M0 for 1 patient, T1N2M0 for 1 patient, T2N1M0 for 4 patients, and T2N2M0 for 4 patients respectively. All patients with N+ underwent concurrent neck dissection; 2 patients underwent concurrent prophylactic tracheotomy; 17 underwent post-operative radiotherapy for 50-66 Gy. The follow-up time was 6-72 months with a median 35 months.Two patients were lost to follow-up. Results: All patients except 2 underwent the TOS successfully, while the two patients were treated with open approach surgery due to unsure safe margin. Most patients returned to oral feeding within one week. Among the 18 patients with complete follow up data, 3 had the local recurrence of the tumor (16.7%) and one died due to local recurrence, multiple primary esophageal carcinoma, and distant metastasis 4 years after surgery (5.6%). According to the Kaplan-Meier method, the 5-years local control rate and survival rate were 57.8% and 67.5% respectively. All patients had no disorders in speech, swallowing and respiration during the follow up. Conclusions: The RFC can be applied in TOS for the treatments of hypopharyngeal carcinoma with high cutting efficiency and better control of intraoperative hemorrhage, which is useful in lowering the operation difficulty. The oncologic results are comparable to the open surgery with satisfactory postoperative organ function preservation. 目的: 初步探讨等离子射频(radiofrequency coblation,RFC)辅助经口手术(transoral surgery,TOS)治疗下咽癌的可行性及有效性。 方法: 回顾性分析2010—2016年接受RFC辅助TOS治疗的22例下咽癌患者,其中梨状窝癌15例,环后癌4例,下咽后壁癌3例;根据AJCC2002年指南,分期为T1N0M0患者3例,T2N0M0患者9例,T1N1M0患者1例,T1N2M0患者1例,T2N1M0患者4例,T2N2M0患者4例。所有术前评估存在淋巴结转移的患者均接受了同期的颈淋巴清扫术,2例患者接受了同期的预防性气管切开术;17例患者接受了术后的放射治疗,剂量范围为50~66 Gy;术后随访时间范围为6~72个月,中位值为35个月。2例患者失访。 结果: 纳入研究的22例患者中2例完成肿瘤切除手术后因肿瘤范围超过术前评估,不能确保安全切缘而中转改为开放手术,其余20例患者均顺利完成TOS治疗。术后除1例患者因疼痛恢复经口进食较慢外,其余患者均在1周内恢复经口进食;完成随访的18例患者中3例(16.7%)局部复发,其中1例(5.6%)因局部复发、多原发食管癌及远处转移于术后4年死亡,根据Kaplan-Meier法计算得到的5年局部控制率及总体生存率分别为57.8%及67.5%。所有患者在随访中均未发现发音、吞咽及呼吸功能等方面的障碍。 结论: RFC辅助TOS治疗下咽癌是可行的,其切割效率高及控制术中出血更佳的特点有助于降低手术的难度,随访的数据证实此类手术疗效确切且患者功能保留率高。.
引用
- Xiao SF, Li WY, Zhang JB, et al. [Transoral radiofrequency coblation surgery for the treatment of hypopharyngeal carcinoma]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017. PMID: 28558449. doi:10.3760/cma.j.issn.1673-0860.2017.05.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。